These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19383340)

  • 21. How can attrition rates be reduced in cancer drug discovery?
    Moreno L; Pearson AD
    Expert Opin Drug Discov; 2013 Apr; 8(4):363-8. PubMed ID: 23373702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flawed arithmetic on drug development costs.
    Subbaraman N
    Nat Biotechnol; 2011 May; 29(5):381. PubMed ID: 21552229
    [No Abstract]   [Full Text] [Related]  

  • 23. Precompetitive research: a new prescription for drug development?
    Woodcock J
    Clin Pharmacol Ther; 2010 May; 87(5):521-3. PubMed ID: 20407454
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of the pharmaceutical industry in drug development in dermatology.
    Cauwenbergh G
    Clin Dermatol; 2002; 20(5):467-73. PubMed ID: 12435516
    [No Abstract]   [Full Text] [Related]  

  • 25. The future costs, risks and rewards of drug development: the economics of pharmacogenomics.
    Cook J; Hunter G; Vernon JA
    Pharmacoeconomics; 2009; 27(5):355-63. PubMed ID: 19586074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pfizer makes breast cancer drug free while NICE decides its future.
    Kmietowicz Z
    BMJ; 2017 May; 357():j2225. PubMed ID: 28483771
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug-diagnostic co-development: how to harness the value.
    Blair ED; Blakemore JA
    Drug Discov Today; 2011 Oct; 16(19-20):902-5. PubMed ID: 21888987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tropical disease: A neglected cause.
    Laursen L
    Nature; 2016 May; 533(7602):S68-9. PubMed ID: 27167396
    [No Abstract]   [Full Text] [Related]  

  • 29. Antibiotic research and development: business as usual?
    Harbarth S; Theuretzbacher U; Hackett J;
    J Antimicrob Chemother; 2015; 70(6):1604-7. PubMed ID: 25673635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Did Medicare Induce Pharmaceutical Innovation?
    Acemoglu D; Cutler D; Finkelstein A; Linn J
    Am Econ Rev; 2006 May; 96(2):103-7. PubMed ID: 29131561
    [No Abstract]   [Full Text] [Related]  

  • 31. Patients not patents: Drug research and development as a public enterprise.
    Gøtzsche PC
    Eur J Clin Invest; 2018 Feb; 48(2):. PubMed ID: 29243246
    [No Abstract]   [Full Text] [Related]  

  • 32. Biomarker strategy in lung cancer.
    Esencay M; Watson A; Mukherjee K; Hanicq D; Gubernick SI
    Nat Rev Drug Discov; 2018 Jan; 17(1):13-14. PubMed ID: 28959953
    [No Abstract]   [Full Text] [Related]  

  • 33. A European initiative to unclog pipeline for new medicines.
    Macleod M; Steckler T
    Nature; 2019 Apr; 568(7753):458. PubMed ID: 31015692
    [No Abstract]   [Full Text] [Related]  

  • 34. The innovative medicines initiative: a European response to the innovation challenge.
    Goldman M
    Clin Pharmacol Ther; 2012 Mar; 91(3):418-25. PubMed ID: 22318619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New players join the drug development game.
    Lott R
    Health Aff (Millwood); 2014 Oct; 33(10):1711-3. PubMed ID: 25288413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Torching the Haystack: modelling fast-fail strategies in drug development.
    Lendrem DW; Lendrem BC
    Drug Discov Today; 2013 Apr; 18(7-8):331-6. PubMed ID: 23246516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. David Haslam. Interview by Asher Mullard.
    Haslam D
    Nat Rev Drug Discov; 2013 Jul; 12(7):500. PubMed ID: 23764976
    [No Abstract]   [Full Text] [Related]  

  • 39. [From a crisis to another...Pharmaceutical industry--economics].
    Scheen AJ
    Rev Med Liege; 2009 Jan; 64(1):3-5. PubMed ID: 19317093
    [No Abstract]   [Full Text] [Related]  

  • 40. Europe bets on drug discovery.
    Baker M
    Nature; 2013 Feb; 494(7435):20. PubMed ID: 23393658
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.